June 24, 2021—BRONX, NY—Today, Albert Einstein Cancer Center (AECC), Albert Einstein College of Medicine, and Montefiore Health System announced that Lauren Hackett, M.P.A., has been appointed the deputy director of administration of AECC and associate vice president of cancer medicine at Montefiore Medicine. Ms. Hackett, who is currently the chief operating officer at the Allen Institute, will assume her new roles in August 2021.

“Lauren has truly distinguished herself in senior administrative leadership roles at top NCI-designated cancer centers and non-profit organizations around the country,” said Edward Chu, M.D., M.S.S., director of AECC; vice president of cancer medicine at Montefiore Medicine; and professor of medicine and of molecular pharmacology, and the Carol and Roger Einiger Professor of Cancer Medicine at Einstein. “She has more than two decades of experience as a mission-driven executive and is accomplished at bringing diverse people and teams together to create and maximize the organizational capabilities of complex, collaborative research institutions. Lauren’s unique skills will help us advance our operations and usher in a new era at the cancer center.”

At AECC, Ms. Hackett will have oversight and authority over the administrative team and structure, running all aspects of its operations. A key part of her role is partnering with the senior leaders at AECC, Einstein, and Montefiore to align and implement strategic priorities across its cancer enterprise.

As COO at the Allen Institute, a private, non-profit research institute in Seattle, WA, she led the institute through the COVID-19 pandemic and co-developed its comprehensive diversity, equity, and inclusion initiative. She also partnered with colleagues to integrate scientific strategy and planning efforts throughout administration and operations teams across the institute.

Lauren’s unique skills will help us advance our operations and usher in a new era at the cancer center.

Edward Chu, M.D., M.S.S.

Previously, Ms. Hackett served for more than seven years as the executive director for administration and chief business officer at the Vanderbilt-Ingram Cancer Center (VICC) in Nashville, TN. She played an integral role in supporting the translation of discovery research into clinical practice at Vanderbilt and helped to transform VICC into one of the elite cancer centers in the U.S. She also served as the executive director for administration at NYU Cancer Institute for seven years and held similar roles with the Yale School of Medicine and Yale Cancer Center. Additionally, she was the director of sponsored programs at Rockefeller University.

Ms. Hackett continues to serve on numerous NCI-designated cancer centers’ external advisory boards as well as peer-review site visit teams and committees for the NCI.